We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
-4.36%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$44.1B
AUM Growth
+$629M
(+1.4%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.51%
Holding
3,945
New
199
Increased
895
Reduced
1,260
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$500M |
| 2 |
Archer Daniels Midland
ADM
|
+$463M |
| 3 |
Hewlett Packard
HPE
|
+$425M |
| 4 |
Gen Digital
GEN
|
+$379M |
| 5 |
WCC
WESCO International
WCC
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$598M |
| 2 |
ExxonMobil
XOM
|
+$504M |
| 3 |
Chevron
CVX
|
+$443M |
| 4 |
Occidental Petroleum
OXY
|
+$439M |
| 5 |
Cummins
CMI
|
+$414M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.1% |
| 2 | Technology | 16.69% |
| 3 | Energy | 13.9% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Anavex Life Sciences
AVXL
$222M
| $5.38K | ﹤0.01% |
1,276
-1,844
| -59% | -$7.46K |
|
1402
Full Truck Alliance
YMM
$9.56B
| $5.23K | ﹤0.01% |
651
-45
| -6% | -$383 |
|
1403
Heron Therapeutics
HRTX
$86.3M
| $5.13K | ﹤0.01% |
+1,465
| New | +$4.5K |
|
1404
C4 Therapeutics
CCCC
$376M
| $4.88K | ﹤0.01% |
1,056
-2,873
| -73% | -$17.1K |
|
1405
Fate Therapeutics
FATE
$281M
| $4.68K | ﹤0.01% |
1,426
-1,968
| -58% | -$8.62K |
|
1406
Oric Pharmaceuticals
ORIC
$1.25B
| $4.67K | ﹤0.01% |
661
+145
| +28% | +$1.3K |
|
1407
Cabaletta Bio
CABA
$439M
| $4.41K | ﹤0.01% |
589
-1,064
| -64% | -$13K |
|
|
VERV
1408
DELISTED
Verve Therapeutics
VERV
| $4.14K | ﹤0.01% |
849
-1,164
| -58% | -$7.32K |
|
1409
ARS Pharmaceuticals
SPRY
$590M
| $4.13K | ﹤0.01% |
485
-31
| -6% | -$275 |
|
1410
Voyager Therapeutics
VYGR
$187M
| $4.02K | ﹤0.01% |
508
-46
| -8% | -$386 |
|
1411
Zentalis Pharmaceuticals
ZNTL
$308M
| $3.9K | ﹤0.01% |
953
-433
| -31% | -$4.84K |
|
|
CRGX
1412
DELISTED
CARGO Therapeutics
CRGX
| $3.78K | ﹤0.01% |
230
+5
| +2% | +$95 |
|
1413
Tango Therapeutics
TNGX
$4.34B
| $3.56K | ﹤0.01% |
415
-607
| -59% | -$4.69K |
|
|
MTLS
1414
Materialise
MTLS
$379M
| $3.2K | ﹤0.01% |
639
-451
| -41% | -$2.32K |
|
1415
Savara
SVRA
$1.13B
| $3.11K | ﹤0.01% |
+771
| New | +$3.43K |
|
|
ITOS
1416
DELISTED
iTeos Therapeutics
ITOS
| $3.04K | ﹤0.01% |
+205
| New | +$2.94K |
|
1417
Matsons
MATX
$6.37B
| $3.01K | ﹤0.01% |
23
-4
| -15% | -$465 |
|
1418
Energizer
ENR
$1.44B
| $2.9K | ﹤0.01% |
98
-1,130
| -92% | -$32.6K |
|
1419
Fortrea Holdings
FTRE
$1.85B
| $2.85K | ﹤0.01% |
122
+17
| +16% | +$528 |
|
1420
Humacyte
HUMA
$168M
| $2.85K | ﹤0.01% |
+593
| New | +$3.09K |
|
|
NVMI
1421
Nova
NVMI
$13.9B
| $2.81K | ﹤0.01% |
12
-266
| -96% | -$52.7K |
|
1422
Stepan Co
SCL
$1.31B
| $2.6K | ﹤0.01% |
31
+4
| +15% | +$342 |
|
1423
Alector
ALEC
$164M
| $2.6K | ﹤0.01% |
572
-716
| -56% | -$3.69K |
|
1424
Sanmina
SANM
$11.2B
| $2.52K | ﹤0.01% |
38
-3
| -7% | -$192 |
|
1425
Camtek
CAMT
$6.9B
| $2.5K | ﹤0.01% |
+20
| New | +$1.91K |
|
Similar funds
SAM
Pacer Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Pacer Advisors held 3,945 positions worth $44.1B, up 1.4% from $43.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pacer Advisors deployed $2.39B of net new capital in Q2 2024, opening 199 new positions and adding to 895 existing holdings. Its largest new stake was Academy Sports + Outdoors: 3,268,629 shares worth $174M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Vistra, an estimated $598M trimmed.
- Pacer Advisors's largest Q2 2024 buy was Academy Sports + Outdoors: 3,268,629 shares worth $174M.
- Pacer Advisors added most to Halliburton in Q2 2024, an estimated $500M increase.
- Pacer Advisors's biggest Q2 2024 reduction was Vistra, cutting an estimated $598M.
- Pacer Advisors fully exited American Eagle Outfitters in Q2 2024, selling an estimated $218M.
- Pacer Advisors's ten largest holdings make up 12% of its $44.1B portfolio in Q2 2024.
- Pacer Advisors opened 199 new positions and closed 190 in Q2 2024.
- Pacer Advisors's portfolio value rose 1.4% quarter-over-quarter to $44.1B.
Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.